Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus by Domingues, Rosana et al.
  Universidade de São Paulo
 
2016
 
Activation of myeloid dendritic cells, effector
cells and regulatory T cells in lichen planus
 
 
Journal of Translational Medicine. 2016 Jun 10;14(1):171
http://www.producao.usp.br/handle/BDPI/50301
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Patologia - FM/MPT Artigos e Materiais de Revistas Científicas - FM/MDT
Domingues et al. J Transl Med  (2016) 14:171 
DOI 10.1186/s12967-016-0938-1
RESEARCH
Activation of myeloid dendritic cells, 
effector cells and regulatory T cells in lichen 
planus
Rosana Domingues1, Gabriel Costa de Carvalho1, Valéria Aoki2, Alberto José da Silva Duarte1 
and Maria Notomi Sato1*
Abstract 
Background: Lichen planus (LP) is a chronic mucocutaneous inflammatory disease. Evaluating the balance between 
regulatory T cells and effector T cells could be useful for monitoring the proinflammatory profile of LP. Therefore, this 
study aimed to assess populations of dendritic cells (DCs) and regulatory and effector T cells in peripheral blood sam-
ples collected from patients with LP to evaluate the polyfunctionality of T cells upon toll-like receptor (TLR) activation.
Methods: Peripheral blood mononuclear cells collected from 18 patients with LP and 22 healthy control subjects 
were stimulated with agonists of TLR4, TLR7, TLR7/TLR8 or TLR9. Frequencies of circulating IFN-α+ plasmacytoid DCs 
(pDCs); TNF-α+ myeloid DCs (mDCs); regulatory T cells (Tregs); and IL-17-, IL-10-, IL-22-, TNF-, and IFN-γ-secreting T cells 
were assessed via flow cytometry.
Results: The frequencies of regulatory CD4+ and CD8+CD25+Foxp3+CD127low/− T cells and TNF-α+ mDCs were 
induced following activation with TLR4, TLR7 and TLR8 agonists in the LP group. Moreover, increased baseline fre-
quencies of CD4+IL-10+ T cells and CD8+IL-22+ or IFN-γ+T cells were found. In the LP group, TLR4 activation induced 
an increased frequency of CD4+IFN-γ+ T cells, while TLR7/8 and staphylococcal enterotoxin B (SEB) activation induced 
an increased frequency of CD8+ IL-22+ T cells. An increased frequency of polyfunctional CD4+ T cells that simultane-
ously secreted 3 of the evaluated cytokines (not including IL-10) was verified upon TLR7/8/9 activation, while poly-
functional CD8+ T cells were already detectable at baseline.
Conclusions: TLR-mediated activation of the innate immune response induced the production of proinflammatory 
mDCs, Tregs and polyfunctional T cells in patients with LP. Therefore, TLR activation has an adjuvant role in inducing 
both innate and adaptive immune responses.
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Background
Lichen planus (LP) is a chronic inflammatory disease that 
affects skin and mucous membranes and can be mediated 
by T cells. Although the aetiology is unknown, LP has 
been associated with human hepatitis C [1] and human 
herpes virus type 7 infections [2].
Previously, we verified that patients with LP exhibit 
dysfunctional cytokine secretion by peripheral blood 
mononuclear cells (PBMCs) after Toll-like receptor 
(TLR) activation. This phenotype was mainly related to 
the activation of intracellular TLRs, including Poly-RIG/
TLR3, imiquimod/TLR7, CL097/TLR7/8, and CpG/
TLR9; similar events occur during viral infection [3]. 
Moreover, we showed that up-regulated expression of 
factors related to the type I IFN axis and antiviral restric-
tion factors as well as enhanced expression of human 
endogenous retroviruses are characteristic of skin lesions 
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in patients with cutaneous LP, attributing a viral aetiol-
ogy to LP pathogenesis [4].
Plasmacytoid dendritic cells (pDCs) are present in large 
numbers in LP skin lesions and have the ability to pro-
duce large amounts of IFN-α in response to TLR7 and 
TLR9 stimulation, showing their key role in antiviral 
responses [2]. In contrast, myeloid dendritic cells (mDCs) 
with immunoregulatory characteristics are also found in 
LP lesions [5]. Understanding the cytokine secretion pro-
files of pDCs and mDCs in peripheral blood could pro-
vide insights into how dendritic cells (DCs) impact T cell 
functions and the balance that exists between regulatory 
and effector responses in LP.
Regulatory T cells (Tregs) play a crucial role in immune 
tolerance and the prevention of autoimmune and inflam-
matory diseases [6, 7]. Tregs express the transcription 
factor Foxp3 and are classified according to their origin 
as either thymus-derived Tregs (tTreg), which recognize 
self antigens, or peripherally derived Tregs (pTreg), which 
recognize antigens from microbiota and allergens as well 
as alloantigens [8]. In oral and cutaneous LP lesions, 
Foxp3+ T cells infiltrate both the epidermis and dermis. 
Moreover, these cells are also found at an increased fre-
quency in the peripheral blood of patients with oral LP 
(OLP) [9, 10]. In cutaneous LP, the presence of these cells 
in peripheral blood has not been evaluated to date.
Increased frequencies of CD4+IFN-γ+ T cells and 
CD4+IFNγ+IL-17+ T cells have been found in the 
peripheral blood of patients with OLP after stimulation 
with phorbol myristate acetate (PMA) and ionomycin 
[11]. Furthermore, CD8+ T cells play an important role 
in LP skin lesions by destroying keratinocytes via the 
induction of apoptosis through FasL expression, the acti-
vation of granzymes and perforin, and the secretion of 
TNF-α [12]. A link between human papillomavirus virus 
infection and OLP pathogenesis has been described, 
including the identification of a massive clonal expan-
sion of CD8+ T cells with an increased frequency of 
HPV-16-specific CD8+ T cell subpopulations in patients 
with OLP [13]. However, in LP, it is unknown whether 
TLR-mediated activation of cells in peripheral blood 
may contribute to the adaptive responses of CD4+ or 
CD8+ T cells, which are mainly related to the secretion 
of IL-17 (Th17/Tc17 cells), IL-22 (Th22/Tc22 cells) and 
IFN-γ (Th1/Tc1 cells).
To date, the generation of polyfunctional responses 
in skin diseases has only been studied in psoriasis and 
atopic dermatitis [14–16]. Polyfunctionality is defined as 
the ability to simultaneously produce multiple cytokines 
and has an important role in viral control. In HIV and 
tuberculosis, polyfunctionality has been associated with 
better vaccine response and slower progression to dis-
ease. Furthermore, polyfunctional cells are targeted when 
designing vaccines and immunotherapies that are medi-
ated though cellular responses [17–19].
In this work, we demonstrated that patients with LP 
have increased frequencies of TNF-α+ mDCs and CD4+/
CD8+ Tregs in their peripheral blood. We also verified 
that TLR activation led to impaired IL-10 production 
by CD4+ T cells and the presence of Th22/Tc22 cells in 
peripheral blood. TLR-mediated signalling events induce 
DC maturation and are crucial to inducing monofunc-
tional or polyfunctional responses by CD4+ and CD8+ T 
cells in patients with LP. Therefore, TLR activation could 
be useful for the immunomodulation of LP.
Methods
Study population
The current study enrolled patients with cutaneous LP 
(n  =  18; 3 males, 15 females) from the Dermatological 
Outpatient Clinic of the Hospital das Clínicas de São 
Paulo (HC-FMUSP) as well as healthy individuals as con-
trols (n = 22; 5 males, 17 females). The majority cohort 
of patients with LP had the cutaneous form of LP and 
association with oral form was observed in 3 patients. 
Patients with other forms of LP, such as lichen plano-
pilaris or drug-induced LP, as well as patients with LP 
associated with autoimmune diseases and other skin dis-
eases were not included. The majority of the patients had 
at least two affected limbs, with papules involving up to 
30 % of the trunk. None of the patients took any type of 
topical or systemic corticosteroids, retinoids or immu-
nosuppressants for 1 month prior to blood collection. A 
serological screening for hepatitis C was performed. The 
median age was 43.9 ±  13.5  years (range: 22–65  years) 
for the patients with LP and 40.5  ±  14.3  years (range: 
20–71 years) for the healthy individuals. All the subjects 
provided written informed consent under the approval 
of the São Paulo University Institutional Use Committee 
(CAPPesq no. 0709/11).
Flow cytometry for Treg analysis
To analyse Treg populations, PBMCs were isolated from 
heparinized venous blood by Ficoll-Hypaque gradient 
centrifugation (GE Healthcare Bio-Sciences AB, Uppsala, 
Sweden) and diluted in RPMI medium supplemented 
with 10 % AB human serum (Sigma, St. Louis, MO, USA). 
The PBMCs were incubated with antibodies against the 
following proteins at 4  °C for 30 min: CD3 (S4.1, Qdot, 
Invitrogen, Carlsbad, CA, USA), CD4 (RPA T4, Hori-
zon V500), CD8 (RPA T8, Alexa Fluor 700), CD45RA 
(HI 100, APC-H7), CCR7 (3D12, Alexa Fluor 647), and 
CD127 (HIL-7R-M21, RPE-Cy7). All antibodies were 
from BD Biosciences (San Jose, CA, USA). The cells were 
then fixed, permeabilized and incubated with an anti-
Foxp3 antibody (PCH101, e-Bioscience, San Diego, CA, 
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USA) at 4  °C for 30  min. The Tregs were characterized 
as CD3+CD4+CD25+CD127low/−Foxp3+ or CD8+CD25+
CD127low/−Foxp3+ and as thymus-derived Tregs (tTregs; 
CD45RA+Foxp3low) or peripherally derived Tregs 
(pTregs; CD45RA−Foxp3high). A total of 400,000 events 
were acquired using a flow cytometer (LSR Fortessa, BD 
Biosciences, USA) with FACS-Diva software (BD Biosci-
ence). The data were analysed using FlowJo software, ver-
sion 9.4.11 (Tree Star, Inc., Ashland, OR, USA).
Evaluation of DCs and effector T cells
Cultures of PBMCs (2.0 ×  106 cells/500  µL) were incu-
bated in 48-well plates (Costar, Cambridge, MA, USA) in 
RPMI 1640 medium with ligands for TLR4 (lipopolysac-
charide, 2 µg/mL), TLR7 (imiquimod, 2.5 µg/mL), TLR7/
TLR8 (CL097, 5 µg/mL), or TLR9 (oligodeoxynucleotide 
CpG, 4 µM/mL) for 16 h or SEB (enterotoxin B of Staphy-
lococcus aureus, 1 μg/mL) as a positive control for 6 h at 
37  °C under 5  % CO2. The stimulus concentrations and 
culture times were previously determined using a dose–
response curve (Cardoso EC, 2013). All the ligands were 
obtained from Invivogen (San Diego, CA, USA). Brefel-
din A (10 µg/mL, Sigma) was added to the cells 4 h after 
the beginning of the culture. mDCs were characterized as 
Lin−CD11c+HLA-DR+, and pDCs were characterized as 
Lin−CD123+HLA-DR+. After the Brefeldin A incubation, 
the cells were washed and incubated with human IgG 
for 10  min followed by staining with LIVE/DEAD (Inv-
itrogen), fixation with Cytofix/Cytoperm solution (BD 
Biosciences) for 20 min and a wash in Perm/Wash solu-
tion. The cells were stained with antibodies against the 
following proteins: Lineage 1 cocktail (SK-7, Lin1, a mix 
of CD3, CD14, CD16, CD19, CD20 and CD56) (FITC), 
HLA-DR (G46-6, Horizon V500), CD123 (7G3, PERCP 
Cy5.5), CD11c (B-ly6, Alexa fluor 700), IFN-α (7N4-1, 
Horizon V500) and TNF-α (6401.111, PE). For mono-
functional and polyfunctional T cell analyses, PBMCs 
were stained with LIVE/DEAD (Invitrogen, viability 
marker), fixed and permeabilized with Cytofix/Cytoperm 
solution (BD Biosciences) and then stained with antibod-
ies against CD3 (SP34-2, BV605), CD4 (RPA-34, Hori-
zon V500), CD8 (RPA-T8, PERCP Cy5.5), TNF (MAb11, 
PECy7), IL-10 (JES3-19F1, APC), CD38 (HIT2, Alexa 
Fluor 700) and IFN-γ (B27, Horizon V450) from BD Bio-
sciences and antibodies against IL-22 (22URTI, PE) and 
IL-17 (N49-653, Alexa Fluor 488) from eBioscience. A 
total of 500,000 events were acquired with a flow cytome-
ter (LSRFortessa, BD) and analysed with FlowJo software. 
The fluorescence minus one (FMO) protocol was used for 
all analyses to determine the gates. Boolean gate arrays 
were then created using FlowJo software. This analysis 
determined the frequency of each cytokine based upon 
all possible combinations of cytokines. To analyse the 
polychromatic flow cytometry data and to generate 
graphical representations of the T cells, the SPICE Pro-
gram was used (Version 2.9, Vaccine Research Center, 
NIAID, NIH).
Statistical analysis
The Mann–Whitney U test was used to compare vari-
ables between the patients with LP and the healthy con-
trols. P ≤ 0.05 was considered significant.
Results
mDCs are responsive to TLR activation in LP
Previously, we verified that mononuclear cells from 
patients with LP have altered cytokine secretion upon 
activation of TLRs with synthetic ligands. This finding 
mainly applies to intracellular TLR7/TLR8 and TLR9 
signalling [3]. One cytokine that is abundantly pro-
duced in PBMCs upon TLR activation is TNF [3]. Based 
on these studies, we analysed the frequency of TNF-α+ 
mDCs within populations of PBMCs [20]. To evaluate the 
responsiveness of DCs (mDCs and pDCs), populations of 
PBMCs were assessed using flow cytometry to determine 
the frequencies of TNF-α+ mDCs and IFN-α+ pDCs after 
stimulation with ligands for TLR4 (LPS), TLR7 (imiqui-
mod) and TLR7/8 (CL097), and TLR9 (CpG) or with SEB 
as a positive control. The gating strategy used to evaluate 
the pDCs and mDCs is depicted in Additional file 1: Fig-
ure S1.
As shown in Fig.  1, an increased frequency of 
CD11c+HLA-DR+TNF-α+ mDCs was found in the LP 
samples after stimulation with LPS/TLR4 and CL097/
TLR7-TLR8. No difference was observed following 
TLR7 activation, indicating that activation of TLR8 
using the CL097 compound in mDCs potently induced 
TNF-α secretion. To induce type I interferon secretion 
by CD123+HLA-DR+ pDCs, we used TLR7 and TLR9 
agonists, which resulted in similar frequencies of IFN-α+ 
pDCs in the LP and HC groups (Fig. 1b).
Patients with LP have an increased frequency of Tregs 
in peripheral blood
To verify that T cells were present in the patients with LP, 
we evaluated populations of tTregs and pTregs, derived 
from thymic or peripheral T cells, respectively [8]. To 
accomplish this goal, we evaluated the frequencies of 
CD4+ and CD8+Foxp3+ Tregs in peripheral blood sam-
ples collected from the LP and HC groups. The gating 
strategy used to identify Tregs is shown in Additional 
file 2: Figure S2.
The patients with LP exhibited increased frequencies of 
CD4+CD25+Foxp3+CD127low/− T cells and CD8+ Tregs 
(Fig. 2a). Among the different subtypes of Tregs analysed, 
we verified that similar frequencies of CD4+ and CD8+ 
Page 4 of 11Domingues et al. J Transl Med  (2016) 14:171 
tTregs were present in both groups (Fig.  2b), while the 
patients with LP had a higher frequency of CD4+ pTregs 
than the healthy controls (Fig. 2c).
Altered cytokine responses in CD4+ and CD8+ T cells were 
induced by TLR activation in patients with LP
Previously, we verified that TLR activation produces 
an adjuvant effect by inducing cytokine production in 
PBMCs [3]. In the current study, we evaluated how stim-
ulation of the innate immune system through TLR activa-
tion in T cells influences LP. Additionally, we stimulated 
PBMCs with TLR agonists such as LPS/TLR4, CL097/
TLR7-8, CpG/TLR9 and SEB and then assessed intra-
cellular levels of IFN-γ, IL-10, IL-22 and TNF in CD4+ 
and CD8+ T cells. The gating strategy used to quantify 
cytokines secreted from T cells is depicted in Additional 
file 3: Figure S3 (a, b).
We assessed the frequencies of CD4+ T cells that 
secreted IFN-γ and IL-10 (Fig. 3) and CD8+ T cells that 
secreted IFN-γ, IL-22 and TNF (Additional file  4: Fig-
ure S4) because these cytokines are specifically modified 
after TLR activation. Relative to the HC group, in the 
patients with LP, CD4+IFN-γ+ T cell frequency increased 
after stimulation with a TLR4 agonist and decreased after 
Fig. 1 TLR activation increased the frequency of TNF-α+ mDC populations in patients with LP. PMBCs from patients with LP (n = 13, closed circles) 
and HC (n = 19, open circles) were left unstimulated or were stimulated with the following TLR agonists: LPS/TLR4, imiquimod/TLR7, CL097/TLR7-
8, CpG/TLR9 and SEB. The cells were incubated with the agonists for 16 h and assessed using flow cytometry. a Production of TNF-α in mDCs 
(CD11c+HLA-DR+TNF-α+). b IFN-α secretion by pDCs (CD123+HLA-DR+IFN-α+) was subtracted from unstimulated levels. The results are shown as 
the mean ± SEM. *P < 0.01 when compared with the HC group
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TLR9 activation, but it was not altered by SEB stimu-
lation (Fig.  3a). Moreover, the patients with LP had a 
higher frequency of unstimulated CD4+IL-10+ T cells, 
whereas this population decreased following TLR4 or 
SEB stimulation.
Unstimulated CD8+ T cells exhibited increased pro-
duction of proinflammatory cytokines, such as IFN-γ and 
IL-22 (Additional file 4: Figure S4). After stimulation with 
CL097/TLR7-8 or SEB, the LP group displayed a high 
frequency of IL-22+ cells (Additional file 4: Figure S4b). 
Upon TLR9 stimulation, the frequency of CD8+ T cells 
secreting TNF or IFN-γ (Additional file  4: Figure S4c) 
decreased in the LP group.
We also evaluated the ratios between Th17 cells and 
Tregs and Th1 cells and Tregs using baseline data (Addi-
tional file 5: Figure S5). These ratios were similar between 
the LP and HC groups.
Patients with LP exhibit increased frequencies of Th22 
and Tc22 cells
To evaluate the frequencies of Th22 and Tc22 cells in 
peripheral blood, we analysed production of the cytokines 
IL-17, IFN-γ and IL-22 in T cells via flow cytometry. Th22 
and Tc22 cells are IL-17−IFN-γ−IL22+, and the gating 
strategy used to identify these cells is shown in Fig.  4a. 
Under no-stimulation conditions, the LP group exhibited 
increased frequencies of Th22 and Tc22 cells compared to 
the HC group; this trend remained for Th22 cells follow-
ing stimulation with SEB (Fig. 4b).
TLR activation induces the production of polyfunctional T 
cells in patients with LP
Next, we evaluated whether stimulation of PBMCs with 
TLRs could induce the production of polyfunctional T 
cells in patients with LP. To accomplish this, we assessed 
levels of the cytokines IL-17, IL-10, IFN-γ, TNF and 
IL-22 in T cells via flow cytometry using a Boolean gating 
strategy, which is described in Additional file  3: Figure 
S3c. As shown in Fig. 5, the patients with LP had fewer 
CD4+ T cells that simultaneously secreted the 5 evalu-
ated cytokines following treatment with CL097 and CpG. 
However, TLR4 or TLR7/8 and TLR9 activation induced 
the production of some of these cytokines in T cells from 
patients with LP, although these cells did not appear to 
produce IL-10. Moreover, in the patients with LP, we 
observed an increased frequency of CD4+ T cells simul-
taneously secreting 3 of the evaluated cytokines com-
pared to the HC following treatment with CL097 or CpG 
(pie chart, yellow slice). Notably, the most prominent 
Fig. 2 The frequencies of CD4+ and CD8+ Treg populations were increased in the peripheral blood of patients with LP. PBMCs obtained 
from patients with LP (n = 18, closed circles) and HC (n = 22, open circles) were assessed by flow cytometry for the presence of (a) 
CD4+ Tregs (CD3+CD4+CD25+Foxp3+CD127low/−) and CD8+ Tregs (CD3+CD8+CD25+Foxp3+CD127low/−), b thymus-derived CD4+ 
Tregs (CD4+CD45RA+Foxp3low) and thymus-derived CD8+ Tregs (CD8+CD45RA+Foxp3low), and (c) peripherally derived CD4+ Tregs 
(CD4+CD45RA−Foxp3high) and peripherally derived CD8+ Tregs (CD8+CD45RA−FoxP3high). The results are shown as the mean ± SEM. *P < 0.05, 
**P < 0.01 when compared with the HC group
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combinations of 3 cytokines in this context included 
IL-22, IL-17, IFN-γ, or TNF, but not IL-10.
The production of polyfunctional CD8+ T cells was 
high in the LP group under no-stimulation conditions 
(Fig.  6). Following stimulation with SEB or CL097, the 
frequencies of CD8+ T cells that simultaneously secreted 
2, 3, or 4 of the above-referenced cytokines increased 
in the samples collected from the patients with LP. 
Although no differences were noted between the groups 
when the cytokines were combined, a different response 
was observed upon activation with CL097 (pie chart, 
Fig. 6).
Discussion
In this report, we identified systemic immunologic altera-
tions that occur in patients with LP, including altered 
innate immune responses caused by mDCs secreting 
TNF and altered effector T cell responses [3]. Moreover, 
our ex vivo evaluation revealed the presence of polyfunc-
tional CD8+ T cells secreting IL-22, IL-17, IFN-γ and/
or IL-10 in parallel with increased numbers of Th22 and 
Tc22 cells and CD8+ and CD4+Foxp3+ Tregs.
Previously, when evaluating PBMCs isolated from 
patients with LP, we observed an increase in TNF secre-
tion following TLR4 or TLR7/TLR8 activation and a 
decrease in TNF following TLR7 activation. A G/A pol-
ymorphism found at position 308 in the gene encoding 
TNF is a risk factor for LP, regardless of the presence 
of HCV infection [21]. Additionally, TNF-α levels are 
increased in the saliva of individuals with OLP and in the 
sera of individuals with cutaneous LP, although the func-
tion of this cytokine in the context of LP is controversial 
[3]. Treatment to produce a TNF blockade can lead to 
the formation of lichenoid reactions in the skin and oral 
mucosa; as such, further studies are required to better 
understand the role of this cytokine in LP pathogenesis.
Given the importance of TNF in skin diseases, we eval-
uated the role of TNF-α in mDC responses to TLR acti-
vation using the compound CL097, which binds to both 
TLR7 and TLR8 (mDCs do not express TLR9). The acti-
vation of TLR4 and TLR7/8 induced an increase in TNF 
responsiveness by mDCs in the LP group. Although dif-
ferences were not found in the co-stimulatory molecules 
CD80 and CD86 (data not shown), the high responsive-
ness of the mDCs to TLR activation could impact T cell 
responses in patients with LP. To evaluate pDC responses, 
we used TLR7 and TLR9 agonists because these recep-
tors are selectively expressed by human pDCs [22, 23]. 
Although these cells are abundant in LP lesions and 
scarce in blood, we found no differences in the periph-
eral blood samples collected from the HCs and patients 
with LP. Previously, we showed that patients with LP have 
increased serum levels of CXCL9 and CXCL10 [3]. These 
chemokines share the CXCR3 receptor, which is up-reg-
ulated in inflamed tissues as well as in pDCs and mDCs. 
The activation of these chemokines through this receptor 
may favour their sequestration in skin lesions. Moreover, 
we also showed that LP skin lesions exhibit an interferon 
type I signature that, interestingly, was related to the 
negative regulation of endogenous retrovirus expression 
Fig. 3 Altered cytokine secretion by CD4+ T cells induced by TLR activation in patients with LP. PBMCs from patients with LP (n = 13, closed circles) 
and HCs (n = 19, open circles) were left unstimulated (a) or were stimulated with the TLR agonists LPS/TLR4, CpG/TLR9 and SEB for 16 h (b) and 
then assessed by flow cytometry for IFN-γ and IL-10 secretion. The frequencies of stimulated CD4+ T cell populations were subtracted from those of 
unstimulated populations. The results are shown as the mean ± SEM. *P < 0.05, **P < 0.01 when compared with the HC group
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[4] and to pDC infiltration into skin lesions, a character-
istic of LP [24]. These cells probably migrate to skin or to 
secondary lymphoid organs, where they induce adaptive 
immune responses such as the induction of Tregs.
The balance between regulatory and effector T cells was 
analysed, and increased percentages of CD4+ and CD8+ 
Tregs were detected in the peripheral blood of patients 
with LP. These peripherally derived Tregs are generated 
outside of the thymus from CD4+CD25− T cell precur-
sors under specific stimulation conditions [25]. Moreo-
ver, unlike CD4+Foxp3+ Tregs, which are generated in 
the thymus, suppressive CD8+Foxp3+Tregs appear after 
primary antigen stimulation, suggesting that these cells 
are amplified by TCR stimulation, as verified in patients 
with inflammatory diseases such as autoimmune type 1 
diabetes and multiple sclerosis [25, 26]. Although we have 
not evaluated the function of these cells, the increased 
frequencies of CD4+ and CD8+ Tregs in the peripheral 
blood of patients with LP seem to control inflammatory 
immune responses in LP skin lesions [27, 28]. Studies of 
Tregs in the cutaneous form of LP are scarce; the major-
ity of studies have examined OLP.
In PBMCs, the activation of TLRs is primarily thought 
to affect antigen-presenting cells by inducing an innate 
immune response that can subsequently activate the 
adaptive immune system. However, an increasing amount 
of data has demonstrated that TLRs are expressed and 
activated in T cells, thus providing evidence for a direct 
role of TLRs in the activation of the adaptive immune 
response [29]. In the current study, we found it most 
appropriate to evaluate the effects of TLR agonists on T 
cells in  vitro while taking into account the involvement 
of DCs in the immune response to mimic the in  vivo 
environment.
Under no-stimulation conditions, the samples 
from the LP group exhibited an increased frequency 
of CD4+IL-10+ T cells, which decreased upon TLR 
activation. In addition, TLR4 activation induced the 
Fig. 4 Frequencies of Th22 and Tc22 cells in HCs and patients with LP. PBMCs obtained from patients with LP (n = 10, black circles) and HCs (n = 19, 
white circles) were left unstimulated or were stimulated with SEB for 16 h and assessed by flow cytometry. A representative gating strategy for the 
selection of CD4+ T cells is shown; the same strategy was used to select CD8+ T cells (a). Production of CD3+CD4+ and CD3+CD8+ (IFN-γ−IL-17−) T 
cells at basal levels (b) and following stimulation with SEB (subtracted from baseline levels) (c). The results are shown as the mean ± SEM. *P < 0.05, 
**P < 0.01 when compared with the HC group
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production of CD4+IFN-γ+ T cells. TLR activation also 
produced a proinflammatory microenvironment, which 
was probably modulated by mDCs and may lead to an 
inflammatory status in patients with LP due to CD4+ T 
cell responses. It is notable that the TLR9 agonist used 
in this study down-regulated cytokine secretion from 
both CD4+ and CD8+ T cells in the LP group. This rela-
tionship suggests that this agonist may be an interesting 
adjuvant to induce tolerance and attenuate inflammatory 
responses in individuals with LP.
Notably, CD8+ T cell activation through TLR7/8 or 
SEB led to an increased frequency of monofunctional 
IL-22+ T cells. Moreover, increased frequencies of Tc22 
and Th22 cells (IFN-γ− and IL-17a−) were detected in 
the patients with LP. These increases could result from 
the migration of IL-22-secreting T cells to sites of skin/
mucosal inflammation. Recent evidence indicates that 
IL-22 is an important cytokine for the protection and tis-
sue remodelling of the skin, whereas Tc22 cells have been 
implicated in the pathogeneses of psoriasis and atopic 
dermatitis [30, 31]. Although the frequencies of the above 
cell populations were increased in the LP group, the roles 
of IL-22 and Th22/Tc22 cells in LP are currently not well 
established and require further study.
Polyfunctional T cells can produce multiple cytokines 
simultaneously, providing a more effective immune 
response to a pathogen than cells that produce only a sin-
gle cytokine [17]. In the LP group, we observed that TLR 
activation in PBMCs induced the production of polyfunc-
tional T cells, mainly through the activation of the TLR7/
TLR8 pathway. Although there were fewer CD4+ T cells 
simultaneously secreting 5 cytokines in the LP group, 
there was an increased frequency of CD4+ T cells simul-
taneously secreting combinations of 2 or 3 cytokines. 
Notably, the absence of the cytokine IL-10 seemed to 
increase polyfunctional CD4+ T cell frequency. Multi-
functional, Th1-skewed cytokine responses (identified 
by the simultaneous secretion of IFN-γ, IL-2, and TNF-
α) have been described to be initiated asynchronously, 
although the ensuing dynamic trajectories of these 
responses evolve in a sequential and systematic manner. 
In LP, we verified that multifunctional CD4+ T cells did 
Fig. 5 Polyfunctional CD4+ T cells are induced upon TLR activation in patients with LP. PBMCs obtained from patients with LP (n = 10, black bars) 
and HCs (n = 19, white bars) were left unstimulated or were stimulated with the following TLR agonists: LPS/TLR4, CL097/TLR7-8, CpG/TLR9 and 
SEB. The cells were incubated with the agonists for 16 h and assessed using flow cytometry. Cytokine production (TNF, IL-22, IL-17, IL-10 and IFN-γ) 
from stimulated CD3+CD4+ T cells was subtracted from the baseline levels. The results are shown as the mean ± SEM. *P < 0.05, **P < 0.01 when 
compared with the HC group
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not secrete IL-10 upon activation, suggesting a possible 
defect in the IL-10 pathway in this cell population.
Polyfunctional T cells (i.e., single cells producing two 
or more immune mediators) play a role in controlling 
HIV and other persistent infections [18, 32]. Although 
polyfunctional T cells represent a very low frequency 
of total CD4+ and CD8+ T cells (in addition to mono-
functional T cells) in HIV patients, these cells could 
lower viral load and have been associated with long-
term suppression of AIDS progression [33]. Moreover, 
HCV-specific T cell responses have been associated with 
effective control of HCV replication [34]. Whether levels 
of unstimulated polyfunctional CD8+ T cells increased in 
association with viral infections in patients with LP must 
be further explored. In our LP cohort, we observed a high 
prevalence of previous viral infections (e.g., cytomegalo-
virus, herpes simplex virus, and Epstein-Barr virus) but 
no cases of infection with HCV, which is the virus typi-
cally associated with LP [4]. Indeed, the aetiology of LP is 
still unclear, although possible causes include viral infec-
tions such as those caused by human herpes virus type 7 
or HCV, which induce multifunctional populations of T 
cells [2, 34].
In summary, we detected a disequilibrium between 
regulatory and effector functions in T cells in the periph-
eral blood of patients with LP. Our results indicated that 
TLR ligands could be used as adjuvants for the modula-
tion of immune responses in LP.
Conclusions
In the current study, we showed that LP is associ-
ated with an altered innate immune response mediated 
through the responses of TNF-α+ mDCs to TLR activa-
tion. Alterations in the production of T effector cells with 
increased Th22/Tc22 subpopulations and impairments in 
IL-10 secretion from CD4+ T cells were induced by TLR 
stimulation. These results suggest the presence of regu-
latory cells in the blood of patients with LP, indicating 
Fig. 6 Polyfunctional CD8+ T cells are induced upon TLR activation in patients with LP. PBMCs obtained from patients with LP (n = 10, black bars) 
and HCs (n = 19, white bars) were left unstimulated or were stimulated with the TLR agonists CL097/TLR7-8 and SEB for 16 h and assessed by flow 
cytometry. Cytokine production (TNF, IL-22, IL-17, IL-10 and IFN-γ) by stimulated CD3+CD8+ T cells was subtracted from the baseline levels. The 
pie chart represents the capacity of T cells to secrete combinations of 5, 4, 3 or 2 cytokines. The results are shown as the mean ± SEM. *P < 0.05, 
**P < 0.01 when compared with the HC group
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that the inflammatory response associated with LP is not 
restricted to the skin. Moreover, polyfunctional T cells 
provide a robust immune response may be useful as an 
adjuvant for the treatment of LP.
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